Pharmacokinetics of LCQ908 in Patients With Renal Impairment
NCT01558323
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
LCQ908
Sponsor
Novartis Pharmaceuticals